Shandong Longzen Pharmaceuticals Co., Ltd. (hereinafter referred to as "Longzen”) has recently acquired and successfully completed the certification process for HACCP (Hazard Analysis and Critical Control Points).
About Longzen
Shandong Longzen Pharmaceutical Co., Ltd. was founded in 2020 and operates as a subsidiary and manufacturing site of Medinoah. Longzen provides integrated and customized solutions across the entire small molecule active pharmaceutical ingredient (API) discovery, development, and manufacturing spectrum. With a dedicated R&D and production team, Longzen supplies more than 300 APIs and/or pharmaceutical intermediates that meet various pharmacopeia standards for multiple applications. In Longzen, we leverage our industry-leading experience and demonstrated track record to help our clients advance their projects and meet the rigorous timelines, ultimately help patients in need.